The Rosacea Research & Development Institute is pleased to announce that
Dr. Neil Shear has graciously volunteered to be a member of the RRDi Medical
Advisory Committee. Dr. Shear joins 22 other health care professionals who are
interested in rosacea research and development. You may see the entire list of
RRDi MAC members at this url >

http://www.irosacea.org/mac.php

Dr. Shear's bio:
Neil H. Shear, MD, FRCPC, FACP
Professor & Chief of Dermatology
Professor of Medicine, Pharmacology, Pediatrics and Pharmacy
University of Toronto, Toronto, Ontario, Canada
Dr. Neil Shear is Professor and Chief of Dermatology at the University
of Toronto Medical School. He graduated with a degree in Engineering Science
from the same university in 1973 and a medical degree from McMaster University
in 1976. Dr. Shear completed training in both Internal Medicine and Dermatology
recognized by the Royal College of Physicians of Canada and the American Boards.
A research fellowship in Clinical Pharmacology, supported by the Medical
Research Council of Canada, was completed at the Hospital for Sick Children in
Toronto. Dr. Shear joined the staff of Sunnybrook Hospital in 1984 and is now
the Head of Dermatology at Sunnybrook & Women's College Health Sciences Centre,
and the Director of the University of Toronto Drug Safety Research Group. Dr
Shear founded the Drug Safety Clinic at Sunnybrook in 1985. He was the founding
chair of CADRAC, the Canadian Adverse Drug Reaction Advisory Committee of Health
Canada. He has conducted clinical trials in dermatology, from first in human
early pharmacology studies to large randomized trials of novel therapeutics in
his role as Vice President of Research and Development (Dermatology) at Ventana
Clinical Research. His research has been funded by numerous peer-reviewed
agencies and the pharmaceutical industry. His main interest is in idiosyncratic
drug reactions that involve the skin. He has published 200 peer reviewed papers
and numerous chapters and abstracts. His clinical interests are diverse, from
rosacea and camouflage makeup to autoimmune blistering diseases. Dr. Shear is a
past president of the Canadian Society for Clinical Pharmacology and a recipient
of the society's Distinguished Service Award. He is the Chair of the Canadian
Association of Professors of Dermatology, President of the Canadian Dermatology
Foundation, and a member of the prestigious American Dermatology Association. In
his spare time he is the founding editor of the Canadian Journal of Clinical
Pharmacology and associate editor of the Journal of Cutaneous Medicine and
Surgery and deputy editor of Journal Watch Dermatology.
_______________________end bio

Brady Barrows
RRDi Director